CAJ | 학술논문

目的：探讨经乳晕弧形切口切除乳腺纤维腺瘤的手术疗效。方法选取95例行乳腺纤维腺瘤切除术的患者为研究对象，回顾性分析其临床资料，根据其切口类型分成经乳晕弧形切口组（A组， n＝55）和放射状切口组（ B组，n＝40）两组。比对两组患者术程、术中出血量、创口直径等手术指标差异，行为期6个月随访，记录其术后相关并发症发生情况。结果①A、B两组患者在术程、术中出血量及创口直径等手术指标对比上均无统计学意义（P＜0．05）；②术后，A组相关并发症发生率为12．7％，同B组的12．5％对比无统计学意义（P＞0．05）；③A组中45例患者术后切口平整，无明显瘢痕且乳房外形无明显改变，B组中仅15例达到上述愈合标准，对比差异明显（P＜0．05）。结论对乳腺纤维腺瘤患者予以经乳晕弧形切口肿瘤切除术，临床疗效显著，术后乳房无明显瘢痕，值得临床推广。
목적：탐토경유훈호형절구절제유선섬유선류적수술료효。방법선취95례행유선섬유선류절제술적환자위연구대상，회고성분석기림상자료，근거기절구류형분성경유훈호형절구조（A조， n＝55）화방사상절구조（ B조，n＝40）량조。비대량조환자술정、술중출혈량、창구직경등수술지표차이，행위기6개월수방，기록기술후상관병발증발생정황。결과①A、B량조환자재술정、술중출혈량급창구직경등수술지표대비상균무통계학의의（P＜0．05）；②술후，A조상관병발증발생솔위12．7％，동B조적12．5％대비무통계학의의（P＞0．05）；③A조중45례환자술후절구평정，무명현반흔차유방외형무명현개변，B조중부15례체도상술유합표준，대비차이명현（P＜0．05）。결론대유선섬유선류환자여이경유훈호형절구종류절제술，림상료효현저，술후유방무명현반흔，치득림상추엄。
Objective This paper was to investigate the curative effect of breast fibroadenomaincision through mammary areola arc incision.Methods Selected 95 cases of breast fibroadenoma resection patients as the research object, a retrospective analysis of their clinical datas was done.The patients were divided into the mammary areola arc incision group (group A,n=55) and the radial incision group (group B,n=40)according to the types of incision.Operation indexes as operation time, amount of bleeding during the operation, the wound diameter were compared, patients in bothtwo groups were followed-up for6 months, recorded related postoperativecomplications.Results The differences of process of operation, intraoperative bleeding volume and contrast diameterof operation wound of the two groups had no statistically significant (P <0.05).Related complication rate in group A was 12.7%, which was similar to12.5%of group B, the difference had no statistically significant (P >0.05).The incisions were smooth in group A, without obvious scar and breast appearancehad no significant change, however, in B grouponly 15 cases reached healing standard, differences between the two groups were significant ( P <0.05).Conclusions The mammary areola arc incision tumor resection of breast fibroadenoma, has significant clinical curative effect, without obvious postoperativescar in breast, it worth of clinical promotion.